PAVmed (PAVM) Free Cash Flow (QoQ) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -68.33% |
| Sep 30, 2025 | 25.25% |
| Jun 30, 2025 | 24.78% |
| Mar 31, 2025 | -1,884.44% |
| Jun 30, 2024 | 11.35% |
| Mar 31, 2024 | -9.07% |
| Dec 31, 2023 | -8.55% |
| Sep 30, 2023 | 12.72% |
| Jun 30, 2023 | 22.35% |
| Mar 31, 2023 | 4.28% |
| Dec 31, 2022 | 12.90% |
| Sep 30, 2022 | 14.20% |
| Jun 30, 2022 | -78.47% |
| Mar 31, 2022 | 28.90% |
| Dec 31, 2021 | -124.19% |
| Sep 30, 2021 | -19.32% |
| Jun 30, 2021 | 26.67% |
| Mar 31, 2021 | -36.64% |
| Dec 31, 2020 | -15.28% |
| Sep 30, 2020 | -4.40% |
| Jun 30, 2020 | -47.56% |
| Mar 31, 2020 | 7.31% |
| Dec 31, 2019 | -42.18% |
| Sep 30, 2019 | -13.26% |
| Jun 30, 2019 | 34.39% |
| Mar 31, 2019 | -28.14% |
| Dec 31, 2018 | -61.93% |
| Sep 30, 2018 | -9.65% |
| Jun 30, 2018 | 22.62% |
| Mar 31, 2018 | -38.61% |
| Dec 31, 2017 | 33.10% |
| Sep 30, 2017 | -188.05% |
| Jun 30, 2017 | 55.00% |
| Mar 31, 2017 | -52.16% |
| Dec 31, 2016 | 2.53% |
| Sep 30, 2016 | 18.17% |
| Jun 30, 2016 | -183.93% |
| Mar 31, 2016 | 18.03% |
| Dec 31, 2015 | -103.92% |
| Sep 30, 2015 | -40.48% |
| Jun 30, 2015 | -292.79% |